Reddit Posts
Up $55K in one trade, pay for college or back into options?
The Week Before: How News Impacted Stock Prices
Undisciplined Traders Google Search After The $BBIO Move : “What Is FOMO”
Undisciplined Traders Google Search After The $BBIO Move : “What Is FOMO”
Hot Stocks: RIGL, KFY gain on earnings; DSEY surges on going-private deal; SHLS, BBIO fall
Hot Stocks: SAVE drops on JBLU deal worries; BBIO jumps 52%; ACRS plunges; PBPB sets high
#BBIO 🔥 Price dropped 70% & since then each day recovering! Should enter for a big JUMP? See Chart
A to B trading. The death-knell of predatory algorithms in the US stock market
Wow BBIO might just explode soon enough.
I need DD/info on the following tickers.
$BBIO Took a potion at $11.25 .. ready for gap up and bounce ✅
BBIO is a bargain after 70% drop!
BBIO down 70% today on disappointing heart drug results. Now looking at CRTX, ALLK, and BBIO for potential swing plays…
Mentions
Noob question here. Been trading in very small amounts just to test the waters and I’m curious what could have caused this: Last week I bought 1 contract of BBIO $45 Call 7/18 at $1.05 average cost. Yesterday, BBIO stock dropped about 0.9% in price, and my option dropped about 17% in value. But wasn’t too concerned seeing as my strike price is still a couple of weeks out. Today, however, BBIO stock is currently up about 0.25% on the day, but my option dropped 98% in value, from 0.58 cents to 0.01 cent. What would cause an option’s value to have such an immediate drop to .01 even if the stock price itself is trading sideways / up a tiny bit? I get that maybe BBIO doesn’t have the momentum to hit $45 by 07/18, but why the immediate tank?
You need to choose very wisely in this sector. Your choice are mostly very poor, so better dont invest in single companies without a clue. Good examples are: VRNA NBIX ARGX MDGL BBIO. Look for solid cashpile (>2 years runway), ideally profitable and also should be commercial stage. Clinical only is mostly risky is you have no clue
Why are you holding gene editing trash like NTLA? Get out of it. Quick biotech lesson - gene therapy or editing are only commercially viable for diseases that are terrible (like a death sentence, particularly for children) and do not have viable alternative therapies that are pretty efficacious already that are generally safe. The two main indications- HAE (busting out in hives…multiple drugs that generally work or will work) and ATTR (lower mortality but PFE/ BBIO/ALNY all have drugs that you would take instead) are not commercially appealing, hence why the stock keeps bleeding down.
BBIO and SWTX tomorrow earnings. SWTX had been in negotiations for a buyout by German Merck for 2 weeks now. BBIO will provide sales updates on its recently approved drug (which is growing rapidly and possibly blockbuster status)
BBIO was quite the ride today
BBIO to 40 after earnings hit
Don’t diss on my BBIO play, they went crazy today 
No it is not baked in. I invest in biotech stocks for 20 years and approval is rarely baked in. Only one time I bought a stock that dropped like a brick on the day of approval and I made money, but it is very rare. The rest always goes up, easily doubles. In the past sometimes it went up to 20 times, not anymore in the last 5 or 6 years I do have APLT that I bought in June for $4.35. I also have BBIO bought in August for $24.15. In the case of BBIO it went up to around $30 then retraced to $21 early this week. BBIO got approved Friday after market closed. Let's see how much it goes up this Monday 11/25
I listed a few last night and am reminded of IOVA and BBIO (just now obsessing over my portfolio.) I think I’ve listed all the ones I am bullish on btw these two comments. The rest I hold in hopes that they will recover a bit, or until inspiration for a smashing good idea strikes.
Ah. Ok. That would be embarrassing (my background is biophysics and I imagined, at first, that I’d be able to choose such things well.) Open positions, shares or bull options, that I still think have legs or are doing ok to well: INZY, BBIO, & MNKD. I’m still holding some that I’ve little hope for and LEAPS calls on IBRX and HUMA.
BBIO flying on competition bad news.
The higher the risk the higher the premium. Selling a covered call gives you downside protection. If you sell a call for $5.00, that means your stock can fall 5.00 before you would be losing money. And if you sold the call for several months out and the stock falls after a couple of months you can buy your call back at a lower price to close out your position and then sell another call further in the future. You can keep renting your stock and in theory your not losing until you actually sell the stock. Biotech stocks are appealing. CORT, BBIO, are examples. I now look at analyst ratings carefully before buying a stock for covered call writing.
I exhaustedly wrote this very late and now realize I failed to include my actual tickers. I thought I had copied them onto the top: It is OGN which most meets those descriptions —————- Just adding: With BBIO as an alternative. ATAI is also a very small bit. I’m making sure to actually copy them in now, as I do recognize the goof.
Still holding $SONG, $MARA, $BBIO, and a tiny slice of $NEGG
Holding $SONG, $MARA, and $BBIO
I trade based on volume profile + flow or flow + catalyst for biotechs. Tech stocks are generally much easier, I look for declining volume and if the monthly chart looks good, I’ll trade it. For bios, I’ll play the run up, as you get closer to whatever event is gonna drive the stock (PDUFA, NDA submission, data readout), the IV on your options gets absolutely juiced and premiums become extremely expensive. I’ll sell some on the way up and lotto a small-decent size through depending on how convicted I am, just watch out for IV crush, you will lose, but when you win, you win big. What I look for in these bios is market size, potential for label expansion, good previous data, little/no competition, and approvability/approved. It doesn’t matter if the data is positive if the company is unable to execute on it, some examples: $HOOK, $DNDN, $ARWR. Also, if there is some ridiculously far OTM put/call flow coming in on a readout or earnings (launch trend), I like to hold my full position through. Worked for $Fibrogen, $BBIO debit spread, $IMGN and $RETA. I’ve also tried trading $SPX weeklies using gamma/delta exposure and it worked, but it was too much work and micro managing. I look for good volume setups or unusual biotech flow in good companies that check the boxes I mentioned previously. I kinda just learned by doing, obviously I didn't go in blind. I learned the basics of options, greeks, and different types of options strategies on youtube, but you'll learn to develop your own trading style with time. If you want to learn how to find/read good flow, check out kiantrades and snorlax\_uw on twitter. Good luck!
I like to trade based on volume profile + flow or flow + catalyst (biotechs). Tech stocks are generally much easier, I look for declining volume and if the monthly chart looks good, I’ll trade it. For bios, I’ll play the run up, as you get closer to whatever event is gonna drive the stock (PDUFA, NDA submission, data readout), the IV on your options gets absolutely juiced and prems become expensive. I’ll sell some on the way up and lotto a small-decent size through depending on how convicted I am. What I look for in these bios is market size, potential for label expansion, previous data, competition, and approvability/approved. It doesn’t matter if the data is positive if the company is unable to execute on it. Also, if there is some ridiculously far OTM put/call flow coming in on a readout or earnings (launch trend), I like to hold my full position through. Worked for $Fibrogen, $BBIO debit spread, $IMGN and $RETA. I’ve also tried trading $SPX weeklies using gamma/delta exposure and it worked, but it was too much work and micro managing. I look for good volume setups or unusual biotech flow in good companies that check the boxes I mentioned previously
I first learned about the basics of what an option is, the greeks, and different strategies (strangles, writing options, spreads, etc) just by watching a couple videos on Youtube. I don't think a lot of people on here trade based on flow, but I learned from twitter just observing this guy named Kiantrades. Once you know what to look for, and make a few trades based on flow, it makes trading SIGNIFICANTLY easier. It essentially tells you where the heavy hitters are putting there money, and in some cases like with $RETA, where insider traders are putting there money. You never really understand it until you actually do it though, there's an intuitive aspect that only comes with trying, in my experience. Once you got your toes in the water, just stick to what you're comfortable with, like I've only ever played long calls/puts, and one debit spread (on $BBIO). If you find yourself taking big losses, only take plays 2-3 months out and use the expiry as downside protection, this saved me a huge amount of money when I took losses on $DIS and $SE. I barely know any TA, but if you can learn how to read/find good flow and you'll be fine. It's one of those things where the only way to truly get better is just by doing, good luck!
90% of biotech flow is often tipped off in my experience. Essentially every name mentioned rarely sees any options volume on normal trading days, so it's extremely suspicious to see some of these names get massive orders like this out of the blue. Before $Fibrogen dropped from $17 to $2, there was a massive amount of OTM put flow. $BBIO, same story but with calls, but I especially went balls deep on this one because the CEO wrote a poem on LinkedIn about overcoming adversity or something one day before their readout. Worked for $IMGN and now $RETA.
I mainly trade off of flow + chart or if there are some upcoming catalysts like earnings or data readouts. I like to play the run-up and will lotto some calls/puts through depending on how convicted I am, ie; is the call/put flow far OTM, how big is the data readout, etc. Worked in the case of $FGEN, $IMGN, $BBIO, $NVDA, and $CVNA, but is risky because of IV crush. For biotechs, fundamentals must be good or you will lose everything on bad data, the amount of bio focused hedgefunds that own the particular stock you're looking at is also a good indicator of how stable/safe of an investment it is
I caught $BBIO @7$ . GOODLUCK!
BridgeBio Pharma (BBIO)...Just look it up.
My ban bet of BBIO hitting $40 is going to lose, I'll see you all in 9 or so days
^[Sokka-Haiku](https://www.reddit.com/user/SokkaHaikuBot/comments/153gt2c/what_is_a_sokka_haiku/?utm_source=share&utm_medium=web2x&context=3) ^by ^awkrawrz: *Will my TSLA, SPY and* *BBIO puts I bought today print* *This week? * ^Remember ^that ^one ^time ^Sokka ^accidentally ^used ^an ^extra ^syllable ^in ^that ^Haiku ^Battle ^in ^Ba ^Sing ^Se? ^That ^was ^a ^Sokka ^Haiku ^and ^you ^just ^made ^one.
Will my TSLA, SPY and BBIO puts I bought today print this week? 
Might buy some more $BBIO and $ACHR. Anyone else holding these two? $RKLB is also looking interesting, and I'll probably pick up some $CCL
$BBIO August 18 $25 puts 👀
$BBIO August 18 $25 put
$BBIO calls made me $1k today :)
Holy fuck $BBIO is making me actual cash. Fu k your meme stocks nerds
Anyone know why biotech stocks $BBIO and $ARGX are pumping bigly?
💰💰💰Get new daily runners and watchlist in our app! #afterhours #watchlist 07/14 $CVKD $BBIO $UUU $TME https://preview.redd.it/y6mu6uqhi0cb1.jpeg?width=576&format=pjpg&auto=webp&s=3585bb0639a12f0b11dab3f68619dad874a2ea65
💰💰💰Get new daily runners and watchlist in our app! #afterhours #watchlist 07/14 $CVKD $BBIO $UUU $TME https://preview.redd.it/28948prdi0cb1.jpeg?width=576&format=pjpg&auto=webp&s=fe13293d6585e2bb3566862381bd8805ec585509
I'm up about 28% on $BBIO. They've had a decent year on a dwarfism drug. Got hammered on Acoramadis in 2021 after some bad phase 3 data but in a couple of weeks they will release 3-year data and it could be a blockbuster for ATTR cardiomyopathy if data proves out. Would be second drug on market for the disease, which ia already a billion dollar drug for Pfizer's tafamadis. Some acquisition rumors. Big time boom or bust. I've rolled the dice after the crash. Just fun money but I believe in the drug.
Thoughts data readout for ATTR-CM trial will have on $BBIO? IV looks very interesting, straddle premiums are at 56%
$BBIO interesting as hell. Retail short interest, buyout rumors after recent trial successes, wild price fluctuations, possibly pulled out of a conference next week. Dunno what it all means but could be some big movements ahead in either direction.
That last 1M bar on BBIO is hilarious.
Well so far $KRTX isn't paying off as immediately as the others did (I'll give $BBIO as an example). It's entirely possible that the underwriters in this case decided not to dump their holdings immediately, even though Goldman Sachs is a primary one just like with $BBIO as they may have incurred sizable losses as a result. $KRTX also has considerable retail investor interest (mostly short) which I was unaware of as these non-scam mid-cap companies tend to fly under the radar. Bad DD on my part. Still might work out though since I have several weeks til expiry in this case. Either way I've been up at least 40% at one point each time I've tried this out and only -10% at the moment (down from up 40 yesterday).
>BridgeBio Pharma Announces Pricing of Public Offering of Common Stock \>BridgeBio Pharma Offering of 8.82 Million Shares Priced at $17 Apiece $BBIO ^\*Walter ^Bloomberg ^[@DeItaone](http://twitter.com/DeItaone) ^at ^2023-03-08 ^07:03:41 ^EST-0500
Not sure if BBIO has more gas in it, v tempted to long after seeing they announced positive phase 2 clinical trial data
>I'm not surprised that BBIO is a strong buy - they have a great pipeline of drug candidates and seem to be well-funded. I'm definitely bullish on their prospects!
**User Report**| | | | :--|:--|:--|:-- **Total Submissions**|3|**First Seen In WSB**|2 weeks ago **Total Comments**|3|**Previous Best DD**| **Account Age**|11 months|[^scan ^comment ](https://www.reddit.com/message/compose/?to=VisualMod&subject=scan_comment&message=Replace%20this%20text%20with%20a%20comment%20ID%20(which%20looks%20like%20h26cq3k\)%20to%20have%20the%20bot%20scan%20your%20comment%20and%20correct%20your%20first%20seen%20date.)|[^scan ^submission ](https://www.reddit.com/message/compose/?to=VisualMod&subject=scan_submission&message=Replace%20this%20text%20with%20a%20submission%20ID%20(which%20looks%20like%20h26cq3k\)%20to%20have%20the%20bot%20scan%20your%20submission%20and%20correct%20your%20first%20seen%20date.) >TL;DR: BBIO is a clinical-stage biopharmaceutical company with a strong pipeline of drug candidates. The company's collaborations and financial resources provide a solid foundation for continued growth, but its success will depend on the outcome of clinical trials and regulatory approval.
What are your positions? One of my main investments is BBIO. Got in around 9 a share
BBIO, I bought in a while back. Average price is 9 per share
$MCRB $NVTA $BBIO $LMND eh
Humanigen HGEN is looking great and I regret not buying stock in it, so on Monday I may just jump on that train and hope it's momentum continues. XELA,XCUR, and TCRT I'm banking on and bought a good amount of stock on. XELA hasn't done much yet. MLFB and NBLD are my wild cards. DSS and TELL are my long-term stocks DAVE and BBIO are finally starting to go up. BBIO has long term potential depending on how their trials go. DAVE may go to fifteen again and then I'll sell. I sold 400 Stocks of MULN, but way too early at $2.01 ... Have another 100 stocks of MULN that I may sell soon.
BBIO 10 bucks. 53 from ATH. ATL 7 bucks. Looks like a pretty solid deal to me for a short squeeze potential
Buy puts on BBIO. I need this to go up
BBIO squeezing like it is squeezing your wife's tits
BBIO short squeeze incoming
The reason why they are working on amyloidosis is because it can be very lucrative, Pfizer’s tafamidis is doing well and ALNY’s main drug is trying to expand its label to catch up. When BBIO failed in December, the perceived risk of failure for ALNY also increased, which is why it fell also the same day.
I wouldn’t view as holding on to the stock as a way of supporting the companies - the amount you hold is trivial and will have no impact to the stock price if you sell. In terms of management teams being professional and passionate, most are just looking out for their economic interests. BBIO: Essentially a west coast version of Roivant now. Management looks for me-too drugs to follow behind a recently established mechanism to try cashing in on its potential. The company’s most important and valuable drug (acquired from Eidos - originally a separate IPO management cashed in on) just horrifically failed a Phase 3 trial, which is why it fell so much in December. This company is a great example of the business model in biotech and is probably dead money. Some will try to speculate on the rest of the pipeline. OCUL: There was an opportunity to cash out at $20 a year ago. This company has been working on sustained release eye conditions and has seen a long, painful process. Hope they can actually get more clinical success in wet AMD, glaucoma, etc. Out of the 3 companies you listed, this probably has the highest potential to rebound. PRTA: This one has a weak pipeline and Alzheimer’s likely won’t look good. While it shot up on hype, it’s on its way down.
Dumping my $MSFT + $BBIO and hoarding oil tomorrow
BBIO buy and let it rebound at $50, sell half and invest in PSEC.
GME for the win!!! What about BBIO?
BBIO for a huge div and gain
I know it's not much, but these stocks have made me about $1500 in a few days of trading. BBIO has been going up steadily and ALLK sidewaysish. But they have been super predictable to swing trade. Just an FYI
Anyone in on BBIO? I bought some shares a few days ago for a nice swing trade. So far I'm very profitable.
BBIO. Dropped like, 75% last week. Making lots of progress. I'm up 70% already.
Anyone watching the BBIO AH movement?
I got APLT for $6.35, may be a long term but I bought BBIO and AUVI after dips and it worked out well for me. Switching my strategy up for 2022. :)
Rolled some OTM BBIO calls into some ITM BBIO calls. Pls.
BBIO everyone jump in before it goes back up
I have an incoming banbet in a few hours. So until next monday, just, BBIO. That is all
BBIO BBIO BBIO....everything is green today. But i love BBIO
BBIO is the play of the day
BBIO had a similar massive one day drop. It went from nearly $10 to at about $17.
Similar to CRTX. I think those drop off plays are very difficult to put on here, at least for now. None of them have shown potential. Only one is BBIO that I’ve seen move forward.
You didn't buy BBIO...did you?